Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00159770
What this trial is testing

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290
Post-approval studies (Phase 4)UnknownNCT02040883
What this trial is testing

Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia

Who this might be right for
Schizophrenia
Qingyun Yin 100
Early research (Phase 1)Study completedNCT04922593
What this trial is testing

Relative Bioavailability of LY03010 Compared to Listed Drug

Who this might be right for
SchizophreniaPsychotic DisordersMood Disorders+9 more
Luye Pharma Group Ltd. 281
Not applicableStudy completedNCT00493233
What this trial is testing

Antipsychotic Polypharmacy in Schizophrenia

Who this might be right for
Schizophrenia
Centre for Addiction and Mental Health 100
Early research (Phase 1)Study completedNCT00791232
What this trial is testing

Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113
Testing effectiveness (Phase 2)Study completedNCT00790517
What this trial is testing

Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

Who this might be right for
Weight LossDiabetes Mellitus, Type 2Psychotic Disorders
Kaiser Permanente 200
Not applicableStudy completedNCT01181960
What this trial is testing

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

Who this might be right for
SchizophreniaBipolar Disorder
Janssen Scientific Affairs, LLC 1,066
Large-scale testing (Phase 3)UnknownNCT01320982
What this trial is testing

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheba Medical Center 400
Not applicableStudy completedNCT06326840
What this trial is testing

Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment

Who this might be right for
Metabolic DisturbanceHyperprolactinemiaSchizophrenia
Taipei Medical University Hospital 42
Large-scale testing (Phase 3)Study completedNCT00249223
What this trial is testing

A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Pharmaceutica N.V., Belgium 641
Large-scale testing (Phase 3)Study completedNCT01235520
What this trial is testing

RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 595
Large-scale testing (Phase 3)Study completedNCT00488319
What this trial is testing

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

Who this might be right for
SchizophreniaSchizophrenic DisordersPsychotic Disorders+1 more
Janssen Research & Development, LLC 400
Not applicableStudy completedNCT02029989
What this trial is testing

Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

Who this might be right for
HyperlipidemiaDiabetesHypertension
University of Minnesota 121
Not applicableStudy completedNCT00406718
What this trial is testing

Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
The University of Texas Health Science Center at San Antonio 197
Testing effectiveness (Phase 2)Study completedNCT02151656
What this trial is testing

F17464 in Acute Schizophrenia Trial

Who this might be right for
Schizophrenia
Pierre Fabre Medicament 158
Not applicableWithdrawnNCT05939765
What this trial is testing

Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.

Who this might be right for
Schizophrenia
Psychiatric University Hospital, Zurich
Post-approval studies (Phase 4)Ended earlyNCT01454453
What this trial is testing

Optimisation of Antipsychotic Drug Use in Older People

Who this might be right for
Alzheimer's DiseaseSchizophrenia
Institute of Psychiatry, London 64
Not applicableStudy completedNCT00363181
What this trial is testing

Side Effects of Antipsychotic Medications

Who this might be right for
Insulin ResistanceMetabolic Syndrome XSchizophrenia and Disorders With Psychotic Features+2 more
Stanford University 76
Not applicableStudy completedNCT02582736
What this trial is testing

Antipsychotics and Risk of Hyperglycemic Emergencies

Who this might be right for
Psychotic DisordersSchizophreniaSchizoaffective Disorder+2 more
Canadian Network for Observational Drug Effect Studies, CNODES 725,489
Not applicableNot Yet RecruitingNCT06651112
What this trial is testing

The ATP Project (Antipsychotic-TEP-Psychosis)

Who this might be right for
First Episose PsychosisMetabolic DiseasePsychosis; Episode
Université de Sherbrooke 18
Next Page